Marc Van den Bergh is Senior Clinical Embryologist and Laboratory Director of the Fertility Laboratory, Kantonsspital Baden, Switzerland. Thomas Ebner is Scientific Lab Director at the Landes- Frauen- und Kinderklinik, Linz, Austria. Kay Elder is Senior Research Scientist, Bourn Hall Clinic, Bourn, Cambridge, UK.

'A great new book for embryologists, although it may also be of interest to all people working in reproductive medicine, and patients too.' The Bulletin of the Royal College of Pathologists

• Introduction; Female indications for treatment; Clinical and laboratory protocols; Controlled ovarian hyperstimulation; Sperm preparation; ICSI; In vitro culture system; Oocyte and embryo assessment; Case histories: Part I. 'KSB': Cleavage Stage Transfer (Case Numbers 1–80): 1. No female indication identified (cases 1–33); 2. Tubal infertility (cases 34–40); 3. Cervical hostility/fibroids (cases 41–44); 4. Endometriosis (cases 45–60); 5. Poor responder or ovulatory dysfunction (cases 61–71); 6. Polycystic ovarian disease (cases 72–74); 7. Hyperprolactinaemia/Hypothyroid (cases 75–79); 8. Recurrent abortion (case 80); Part II. 'Linz': Extended Culture to Blastocyst Stage (Case Numbers 81–111): 9. No female indication identified (cases 81–92); 10. Unexplained, failed IVF (cases 93–94); 11. Tubal infertility (cases 95–98); 12. Endometriosis (cases 99–102); 13. Polycystic ovarian disease (cases 103–109); 14. Premature ovarian failure (case 110); 15. Translocation (case 111).

Marc Van den Bergh is Senior Clinical Embryologist and Laboratory Director of the Fertility Laboratory, Kantonsspital Baden, Switzerland. Thomas Ebner is Scientific Lab Director at the Landes- Frauen- und Kinderklinik, Linz, Austria. Kay Elder is Senior Research Scientist, Bourn Hall Clinic, Bourn, Cambridge, UK.

'A great new book for embryologists, although it may also be of interest to all people working in reproductive medicine, and patients too.' The Bulletin of the Royal College of Pathologists

• Introduction; Female indications for treatment; Clinical and laboratory protocols; Controlled ovarian hyperstimulation; Sperm preparation; ICSI; In vitro culture system; Oocyte and embryo assessment; Case histories: Part I. 'KSB': Cleavage Stage Transfer (Case Numbers 1–80): 1. No female indication identified (cases 1–33); 2. Tubal infertility (cases 34–40); 3. Cervical hostility/fibroids (cases 41–44); 4. Endometriosis (cases 45–60); 5. Poor responder or ovulatory dysfunction (cases 61–71); 6. Polycystic ovarian disease (cases 72–74); 7. Hyperprolactinaemia/Hypothyroid (cases 75–79); 8. Recurrent abortion (case 80); Part II. 'Linz': Extended Culture to Blastocyst Stage (Case Numbers 81–111): 9. No female indication identified (cases 81–92); 10. Unexplained, failed IVF (cases 93–94); 11. Tubal infertility (cases 95–98); 12. Endometriosis (cases 99–102); 13. Polycystic ovarian disease (cases 103–109); 14. Premature ovarian failure (case 110); 15. Translocation (case 111).

Marc Van den Bergh is Senior Clinical Embryologist and Laboratory Director of the Fertility Laboratory, Kantonsspital Baden, Switzerland. Thomas Ebner is Scientific Lab Director at the Landes- Frauen- und Kinderklinik, Linz, Austria. Kay Elder is Senior Research Scientist, Bourn Hall Clinic, Bourn, Cambridge, UK.

'A great new book for embryologists, although it may also be of interest to all people working in reproductive medicine, and patients too.' The Bulletin of the Royal College of Pathologists

• Introduction; Female indications for treatment; Clinical and laboratory protocols; Controlled ovarian hyperstimulation; Sperm preparation; ICSI; In vitro culture system; Oocyte and embryo assessment; Case histories: Part I. 'KSB': Cleavage Stage Transfer (Case Numbers 1–80): 1. No female indication identified (cases 1–33); 2. Tubal infertility (cases 34–40); 3. Cervical hostility/fibroids (cases 41–44); 4. Endometriosis (cases 45–60); 5. Poor responder or ovulatory dysfunction (cases 61–71); 6. Polycystic ovarian disease (cases 72–74); 7. Hyperprolactinaemia/Hypothyroid (cases 75–79); 8. Recurrent abortion (case 80); Part II. 'Linz': Extended Culture to Blastocyst Stage (Case Numbers 81–111): 9. No female indication identified (cases 81–92); 10. Unexplained, failed IVF (cases 93–94); 11. Tubal infertility (cases 95–98); 12. Endometriosis (cases 99–102); 13. Polycystic ovarian disease (cases 103–109); 14. Premature ovarian failure (case 110); 15. Translocation (case 111).